Treatment of older patients with non-small-cell lung cancer: walking the therapeutic tightrope.
作者信息
Simon George R
出版信息
J Clin Oncol. 2010 Feb 1;28(4):523-6. doi: 10.1200/JCO.2009.25.3773. Epub 2009 Dec 28.
PMID:20038720
Abstract
摘要
相似文献
1
Treatment of older patients with non-small-cell lung cancer: walking the therapeutic tightrope.老年非小细胞肺癌患者的治疗：在治疗的钢丝绳上行走
J Clin Oncol. 2010 Feb 1;28(4):523-6. doi: 10.1200/JCO.2009.25.3773. Epub 2009 Dec 28.
2
Waging war on lung cancer.向肺癌宣战。
FDA Consum. 1999 May-Jun;33(3):7-8, 10-1.
3
Manage patients with non-small cell lung cancer.治疗非小细胞肺癌患者。
ONS Connect. 2008 Oct;23(10):20-1.
4
Individualised treatment in non-small cell lung cancer: precise tissue diagnosis for all?非小细胞肺癌的个体化治疗：所有人都需要精准组织诊断吗？
Thorax. 2011 Apr;66(4):273-5. doi: 10.1136/thx.2010.138370. Epub 2011 Feb 23.
5
[Possibilities of chemotherapy in patients with bronchial cancer].
Rontgenblatter. 1988 Mar;41(3):113-6.
6
7
Failure of vinorelbine to produce responses in pretreated non-small cell lung cancer patients.
Anticancer Res. 1994 May-Jun;14(3B):1413-5.
8
Adjuvant chemotherapy in patients 80-89 years of age with non-small cell lung cancer.80至89岁非小细胞肺癌患者的辅助化疗
Eur J Cardiothorac Surg. 2005 Dec;28(6):911-2; author reply 912. doi: 10.1016/j.ejcts.2005.09.002. Epub 2005 Oct 19.
9
Recent advances in chemotherapy for lung cancer.肺癌化疗的最新进展。
Curr Opin Pulm Med. 1996 Jul;2(4):285-9.
10
A phase II study of the dolastatin 15 analogue LU 103793 in the treatment of advanced non-small-cell lung cancer.多拉司他汀15类似物LU 103793治疗晚期非小细胞肺癌的II期研究。
Am J Clin Oncol. 2003 Aug;26(4):336-7. doi: 10.1097/01.COC.0000020962.25210.6F.
Zotero 插件